STAT+: Boston Scientific completes $1 billion acquisition of Israeli firm
Boston Scientific’s shopping spree for smaller medical-device companies continued on Wednesday when the Marlborough-based company…
Category: Biotech
Congress demands documents from FDA on controversial approval of Biogen’s Alzheimer’s drug
WASHINGTON — Lawmakers have requested data and documents from the Food and Drug Administration related…
STAT+: Pharmalittle: Purdue bankruptcy plan is approved but appeals expected; FDA warns about safety risks with arthritis drugs
Top of the morning to you. And a fine one it is. Lots of sunshine…
Opinion: Hospital mergers and acquisitions are a bad deal for patients. Why aren’t they being stopped?
Contrary to what health care executives advertise, hospital mergers and acquisitions aren’t good for patients….
Opinion: Hold insurers accountable for covering HIV prevention drugs at no cost to patients
Even before the Affordable Care Act reduced uninsured rates in our country, it required private…
STAT+: The next front in the health care cloud wars
After a mad rush to roll out telehealth offerings during the pandemic, the value of…
The debate over Covid-19 vaccine boosters, what to call them, and whether they’re needed
U.S. health officials want you to get another shot of Covid-19 vaccine. But some experts…
Vaccination reduces risk of long Covid, even when people are infected, U.K. study indicates
People who are fully vaccinated against Covid-19 appear to have a much lower likelihood of…
Judge approves Purdue’s controversial bankruptcy plan, paving the way for immunity for Sacklers
After two years of contentious bargaining, a U.S. bankruptcy court judge on Wednesday approved a…
Scientists engineer nasal cartilage cells to repair aching knees
In osteoarthritis of the knee, cartilage that should cushion the bones erodes, leaving people in…
STAT+: Pharmalittle: Two key FDA officials leaving amid Covid-19 booster debate; is Biden really ‘following the science’?
Hello, everyone, and welcome to the middle of the week. You made it this far,…
Opinion: Listen: An ICU physician on the moral dilemmas mechanical ventilators can raise
On the day in 1928 when the inventors of the iron lung wheeled their contraption…
Opinion: Two insurance-based ways to get more Americans vaccinated
With 40% of Americans completely unvaccinated against Covid-19 — blame it on political polarization, virulent…
Opinion: Africa has a chance to help the world end polio for good. It needs to seize it now
One year ago, I joined African leaders, experts, and global partners to mark an extraordinary…
STAT+: The 10 power players to watch on Democrats’ drug pricing push
WASHINGTON — In the coming weeks, Democrats will embark on an ambitious effort to change…
Biden pledged to ‘follow the science.’ But experts say he’s sometimes fallen short
WASHINGTON — It’s a mantra that President Biden has repeated since the early days of…
How one vape shop is openly defying FDA regulations
D.C. Diagnosis is STAT’s weekly newsletter about the politics and policy of health and medicine….
Elizabeth Holmes on trial, an e-prescribing glitch, & Uber invades Texas
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Two top FDA officials in charge of Covid-19 vaccines to leave agency this fall
WASHINGTON — The two officials in charge of leading the FDA’s review of coronavirus vaccine…
STAT+: STAT+ Conversation: Theranos returns
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: BIO wrestles with inner turmoil; J&J HIV vaccine failed to prevent infection
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
Johnson & Johnson’s HIV vaccine fails first efficacy trial
An HIV vaccine using the same basic technology as Johnson & Johnson’s Covid shot failed…
Opinion: Liquid biopsy: misplaced faith in early cancer detection?
The trial of Theranos CEO Elizabeth Holmes for defrauding investors about the company’s blood tests…
Watch: As Elizabeth Holmes stands trial on fraud charges, catch up on the Theranos saga
Elizabeth Holmes was poised to become the next college-dropout-turned-tech-billionaire. But there was only one problem:…
Opinion: ‘This Is My Story’: connecting clinicians with hospitalized patients who can’t speak for themselves
During the maelstrom of Covid-19 in April 2020, I assisted in a birth at Johns…
What to watch for as the long-awaited Elizabeth Holmes fraud trial unfolds
After two delays, two documentaries, and enough podcast hours to fill even the longest of…
STAT+: ‘Change is messy’: Inside the tumultuous efforts to stabilize BIO, the biotech lobby
WASHINGTON — The Biotechnology Innovation Organization, the lobbying group that represents roughly 1,000 biotech companies,…
STAT+: ‘A step in the right direction for national security’: An antibiotic plant reopens in Tennessee to make penicillin
Amid a push to bolster antibiotic manufacturing in the U.S., a facility that closed last…
STAT+: Flagship’s Laronde raises $440 million for a new class of medicines
Flagship Pioneering, the Cambridge, Mass., venture capital firm, brought biotech startup Laronde out of stealth…
Opinion: 3 surprising trends in seniors’ telemedicine use during the pandemic
The explosive growth in telemedicine has been hailed by some as an important “silver lining”…
STAT+: Pharmalittle: Contaminants found in Moderna Covid-19 vaccine in Japan; demand rises for ivermectin to treat the coronavirus
Good morning, everyone, and nice to see you again. We have returned from a week-long…
.jpg)
Opinion: A perfect storm: Climate disasters are magnifying the U.S.’s maternal health crisis
During every humanitarian disaster — whether it’s a war, a pandemic, or an extreme weather…
STAT+: 4 ways Elizabeth Holmes could win over a jury
Elizabeth Holmes may be guilty in the minds of millions who consumed the best-selling book,…
Inside Pfizer’s labs, ‘variant hunters’ race to stay ahead of the pandemic’s next twist
PEARL RIVER, N.Y. — Delta was tearing its way through India and, as the death…
Opinion: I was once a hardcore anti-vaxxer. Now I try to nudge people to get the Covid-19 vaccine
I open the email from a Facebook friend who recently told me they were against…
STAT+: Pharmalittle: Judge delays ruling on Purdue opioid settlement; Biomarin dwarfism drug cleared in Europe
Good day, everyone! Nick Florko here filling in for the great Ed Silverman. I’m here…
Does breast density matter for older women’s risk of cancer?
Breast density is a known risk factor for developing breast cancer, but that well-accepted research…
Opinion: It’s easy to judge the unvaccinated. As a doctor, I see a better alternative
I don’t ask “Why?” when a patient with Covid-19 tells me they are unvaccinated for…
STAT+: Biden health department hires four outside firms to audit Covid-19 grants to hospitals
WASHINGTON — The Biden administration has hired several separate outside contractors to police the billions…
‘Tired of worrying’: As some parents press for vaccines off-label, pediatricians call for patience
Just hours after the Food and Drug Administration announced full approval for the Pfizer/BioNTech Covid-19…
Listen: Vaccine mandates, biotech’s messy summer, & a pharmaceutical thriller
What’s standing in the way of mandatory Covid-19 vaccination? Is biotech in a credibility crisis?…
Verily and Mayo Clinic team up on a tool to support clinicians
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Judge plans to rule on Purdue settlement Friday; Biden administration considering Covid boosters after six months
Good morning, fellow humans. Erin Brodwin here, filling in for Ed Silverman. My unofficial mascot,…
Opinion: My aunt’s ‘Kafkaesque journey’ to get the home care she needed
As an attorney who has concentrated in elder law and long-term care rights for more…
Opinion: Expanding the domestic public health supply chain is a matter of national security
One of the many hard lessons learned from Covid-19 has been that a robust and…
STAT+: The Theranos scandal cast a pall over self-testing. The pandemic is giving the industry another shot
This could have been Elizabeth Holmes’ moment. When the then-19-year-old founded Theranos in 2003, she…
STAT+: Sesen Bio pulls E.U. application for FDA-rejected cancer drug
Sesen Bio, a small biotech firm whose investigational cancer treatment once seemed poised for approval,…
Mental health giants Headspace and Ginger to merge into $3 billion company
Headspace and Ginger, two of the most prominent companies in the increasingly competitive mental health…
STAT+: Pharmalittle: Second J&J vaccine dose boosts antibodies against Covid; age lowered for diabetes screening
Good morning! Katie Palmer here, tagging in for Ed Silverman as he embraces the final…
Opinion: Listen: A father describes the legacy of his son’s ultra-rare disease
Bertrand Might was born with a rare disease that had never before been diagnosed, an…